HFA Premium Access

Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Riccardo Maria Inciardi

Civil Hospital of Brescia, Brescia (Italy)
0 follower

5 more presentations in this session

Cardiomyocyte-specific overexpression of GCH1 mitigates heart failure with preserved ejection fraction through inhibiting iNOS-mediated nitrosative stress

Speaker: Doctor Y. Cai (Hong Kong, HK)

Thumbnail

Machine learning unveils distinctive proteomic signatures in heart failure with preserved ejection fraction: insights into sex-specific profiles

Speaker: Ms A. Schoeber (Mainz, DE)

Thumbnail

Prognostic significance of left atrial diameter to left ventricular diastolic diameter ratio in patients with heart failure with preserved ejection fraction

Speaker: Doctor S. Suzuki (Matsumoto, JP)

Thumbnail

Use of fluid challenge as a diagnostic tool in patients with dyspnea and preserved ejection fraction

Speaker: Doctor C. Pereira Mateus (Amadora, PT)

Thumbnail

Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: analysis of safety outcomes of the REBALANCE-HF randomized trial

Speaker: Doctor M. Fudim (Durham, US)

Thumbnail

Access the full session

Chronic heart failure - pathophysiology and mechanisms 8

Speakers: Doctor R. Inciardi, Doctor Y. Cai, Ms A. Schoeber, Doctor S. Suzuki, Doctor C. Pereira Mateus...
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations